Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04536675 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of Nov 2023 to Apr 3, 2026v3 Show 5 more changesShow less
    • Primary endpoint revised
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Apr 2024 to Sep 2026
    • Secondary endpoints: 15 to 20
    • Site details revised
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 2020 to Apr 1, 2021
    • Study sites: 0 to 1
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a double-blind randomized controlled trial evaluating the effect of perioperative dual bronchodilator therapy on post-operative pulmonary function and health-related quality of life (QoL) in mild-to-moderate less symptomatic COPD patients undergoing lung cancer surgery. Investigators hypothesized that dual bronchodilator, as compared with placebo, would prevent reduction of pulmonary function after surgical resection and improve postoperative health related QoL.
Trial Details
NCT Number NCT04536675
Lead Sponsor Samsung Medical Center
Conditions
(from sponsor)		 Chronic Obstructive Pulmonary Disease, Non Small Cell Lung Cancer
Related terms Carcinoma, Non-Small-Cell Lung, Pulmonary Disease, Chronic Obstructive
Enrollment 204 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov